Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016;6(1):1-15.
doi: 10.3233/JPD-150769.

Retrograde Axonal Degeneration in Parkinson Disease

Patricia Tagliaferro  1 , Robert E Burke  1   2
Affiliations
Free PMC article
Review

Retrograde Axonal Degeneration in Parkinson Disease

Patricia Tagliaferro et al. J Parkinsons Dis. 2016.
Free PMC article

Abstract

In spite of tremendous research efforts we have not yet achieved two of our principal therapeutic goals in the treatment of Parkinson's disease (PD), to prevent its onward progression and to provide restoration of systems that have already been damaged by the time of diagnosis. There are many possible reasons for our inability to make progress. One possibility is that our efforts thus far may not have been directed towards the appropriate cellular compartments. Up until now research has been largely focused on the loss of neurons in the disease. Thus, neuroprotection approaches have been largely aimed at blocking mechanisms that lead to destruction of the neuronal cell body. Attempts to provide neurorestoration have been almost entirely focused on replacement of neurons. We herein review the evidence that the axonal component of diseased neuronal systems merit more of our attention. Evidence from imaging studies, from postmortem neurochemical studies, and from genetic animal models suggests that the axons of the dopaminergic system are involved predominantly and early in PD. Since the mechanisms of axonal destruction are distinct from those of neuron cell body degeneration, a focus on axonal neurobiology will offer new opportunities for preventing their degeneration. At present these mechanisms remain largely obscure. However, defining them is likely to offer new opportunities for neuroprotection. In relation to neurorestoration, while it has been classically believed that neurons of the adult central nervous system are incapable of new axon growth, recent evidence shows that this is not true for the dopaminergic projection. In conclusion, the neurobiology of axons is likely to offer many new approaches to protective and restorative therapeutics.

Keywords: Axons; Wallerian degeneration; autophagy; neurodegeneration.

PubMed Disclaimer

Figures

Fig.1
Fig.1
Each panel shows nigrostriatal axons in the MFB visualized by confocal microscopy in TH-GFP mice. Following deletion of Atg7, axons of SNpc dopamine neurons are resistant to retrograde axon degeneration. In the absence of AAV Cre injection, Atg7fl/fl:TH-GFP mice show a loss of MFB dopaminergic axons, and the appearance of axonal spheroid pathology (red arrows) following unilateral 6OHDA injection. Atg7wt/wt:TH-GFP mice injected with AAV Cre show a similar axon loss and pathology. However, following injection of AAV Cre, Atg7fl/fl:TH-GFP mice show minimal axon loss and pathology following 6OHDA injection. Atg7fl/fl:TH-GFP mice without AAV Cre (n = 5) and Atg7wt/wt:TH-GFP mice given AAV Cre (n = 6) show a mean loss of 31 (or 32% ) and 32 (or 34% ) MFB axons respectively, whereas Atg7fl/fl:TH-GFP mice treated with AAV Cre (n = 6) show a mean loss of only 5 (or 5% ) (p <  0.001, ANOVA).
Fig.2
Fig.2
Transmission electron microscopic analysis of axonal spheroids in the medial forebrain bundle in the hLRRK2(R1441G) BAC transgenic mice revealed the presence of giant axonal spheroids containing large numbers of autophagic vacuoles. In A, a thinly myelinated axon (arrowheads) with well-organized cytoskeletal elements leads into a large spheroid that lacks myelin, contains disorganized cytoskeletal structures and is packed with autophagic vacuoles. The region in the white box is shown at higher magnification in B. Numerous vacuoles with double membranes, characteristic of autophagic vacuoles (AV), are observed. Interspersed among them are numerous multilamellar bodies (MLB).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, & Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology, 68, 384–386. - PubMed
    1. Kowal SL, Dall TM, Chakrabarti R, Storm MV, & Jain A (2013) The current and projected economic burden of Parkinson’s disease in the United States. Mov Disord, 28, 311–318. - PubMed
    1. Olanow CW, Kieburtz K, & Schapira AH (2008) Why have we failed to achieve neuroprotection in Parkinson’s disease? Ann Neurol, 64(Suppl 2), S101–S110. - PubMed
    1. Finn JT, Weil M, Archer F, Siman R, Srinivasan A, & Raff MC (2000) Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J Neurosci, 20, 1333–1341. - PMC - PubMed
    1. Le WD, Chen S, & Jankovic J (2009) Etiopathogenesis of Parkinson disease: A new beginning? Neuroscientist, 15, 28–35. - PubMed

Publication types